America Great Health
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AAGH research report →
About the company
Operating as a U. S. -based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements.
- CEO
- Mike Qingkun Wang
- IPO
- 2012
- Employees
- 5
- HQ
- Alhambra, CA, US
Price Chart
- Market Cap
- $2.12M
- P/E
- 3.28
- P/S
- 5.38
- P/B
- -0.46
- EV/EBITDA
- 3.68
- Div Yield
- 0.00%
- Gross Margin
- 70.28%
- Op Margin
- -100.10%
- Net Margin
- 163.88%
- ROE
- -11.81%
- ROIC
- 23.80%
- Revenue
- $391.74K · 32.94%
- Net Income
- $-721,242 · 40.91%
- EPS
- $0.00 · 100.00%
- Op Income
- $-382,935
- FCF YoY
- 45.93%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 5.62
- Avg Volume
- 295.22K
Get TickerSpark's AI analysis on AAGH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AAGH coverage
Recent articles, reports, and earnings notes.
No research on AAGH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AAGH report →Similar companies
Peers in the same neighborhood.